Does endometrial αvβ3 vitronectin (β3) expression in endometriosis (ENDO) patients predict enhanced outcomes after prolonged GnRH agonist (GnRHa) therapy prior to in vitro fertilization (IVF)?

Eric S. Surrey, A K Lietz, R.L. Gustofson, D.A. Minjarez, William B. Schoolcraft
In: Fertility and Sterility · 2007 · vol. 88 , pp. S137 · doi:10.1016/j.fertnstert.2007.07.440 · W2055071812
article OA: closed CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated whether endometrial αvβ3 vitronectin expression in endometriosis patients predicts improved outcomes following prolonged GnRH agonist therapy before IVF.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK